BWAY Brainsway Ltd. American Depositary Shares Surgical & Medical Instruments & Apparatus Best Medical Devices Stocks 2026 →

Brainsway (BWAY) Stock: Buy, Sell, or Hold?

$10.67
-0.97 (-8.33%) ▼
5d: -4.3% 30d: -6.89% 90d: -35.72%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$11.12 – $11.91
Position: OVERSOLD
Forward P/E & Valuation
21.1x CHEAP
vs 41.3x historical avg
Wall Street Target
$19.27
+80.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.21 / $12.25
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BWAY shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When BWAY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$24.67
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.32
30.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BWAY is currently trading at $10.67, which is considered oversold relative to its 30-day fair value range of $11.12 to $11.91. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.1) compared to its historical average (41.3). Remarkably, the market is currently pricing in an annual earnings decline of 20.1% over the next few years. This pessimistic expectation contrasts with the company's recent 59.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, BWAY is in a strong downtrend. Immediate support is located at $10.21, while resistance sits at $12.25. Short-term momentum is weak, with the stock down 8.3% recently.

Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.27 (+80.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $11.12 - $11.91
Company Quality Score 38/100 (SELL)
Volume Confirmation HIGH
Confidence Score 74.8%

Trading Range & Key Levels

30-Day Trading Range $11.12 - $11.91
Current vs Trading Range OVERSOLD
Support Level $10.21
Resistance Level $12.25
Current Trend Strong Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (47/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-8.3%)
  • BULLISH: Trading 80.6% below Wall St target ($19.27)
  • WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 21.06
Wall Street Target $19.27 (+80.6%)
Revenue Growth (YoY) 35.4%
Earnings Growth (YoY) 59.8%
Profit Margin 15.6%
Valuation Discount vs History -20.1% cheaper
PE vs Historical 21.1 vs 41.3 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -20.1% (market-implied from PE analysis)
1-Year Target $9.60 (-10%)
2-Year Target $8.64 (-19%)
3-Year Target $7.78 (-27%)
3-Yr Target (if PE normalizes) (PE: 21→41) $15.26 (+43%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.1, Growth: 65.2%) $36.01 (+238%)
Base: (SPY PE: 19.9, Growth: 65.2%) $33.96 (+218%)
Bear: (PE: 16.9, Growth: 65.2%) $28.87 (+171%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (49x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 48.50 | Current EPS (TTM): $0.24
Bull Case $25.61 (+140%)
Analyst growth 100.0%, PE expands to 53.4
Base Case $23.28 (+118%)
Market implied 100.0%, PE stable at 48.5
Bear Case $7.92 (-26%)
Severe decline -20.0%, PE contracts to 41.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.1 to 41.3
Stabilization Target: $20.93 (+96.1%)
PE Expansion Potential: +96.1%
Share BWAY Analysis

Share this live BWAY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (BWAY)

Bullish 1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Apr 22, 2026
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on BWAY are bullish (sentiment score +0.82) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:34 AM ET
Data refreshes hourly during market hours. Next update: 9:34 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BWAY.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$98 47 HOLD
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$112 42 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 37 SELL
SYK
Stryker Corporation
STRONG BUY
30 analysts
$340 31 SELL
GEHC
GE HealthCare Technologi…
STRONG BUY
22 analysts
$88 33 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive BWAY Research Pages
BWAY Technical Chart BWAY Price Prediction BWAY Intrinsic Value DCF BWAY Earnings Date Why is BWAY Moving Today? BWAY Investment Advisor BWAY Fair Price Analyzer BWAY Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals